ECDC opens ESCAIDE 2024 conference

News

The 2024 European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE) is taking place from 20 - 22 November 2024 in Stockholm, Sweden, and has a special focus on the latest research concerning COVID-19, food-and waterborne diseases, HIV and sexually transmitted infections, vaccine-preventable diseases, influenza and respiratory viruses, antimicrobial resistance, and emerging diseases.

Plenary sessions feature internationally renowned speakers who will discuss a range of critical topics, including the balance of prevention versus cure with lessons drawn from cancer, crime, and climate change; insights on infectious diseases during times of conflict with a focus on Ukraine; and strategies for improving surveillance to better understand the spread of infectious diseases. Other discussions will cover preparedness for emerging threats under the concept of ‘Disease X’ and a fresh look at the future management of known diseases. 

Dr. Piotr Kramarz, ECDC Chief Scientist. said:

“ESCAIDE 2024 is an important conference that highlights the importance of collaboration in infectious disease prevention and control. This gathering provides an invaluable platform for experts from diverse fields to exchange insights, share research, and strengthen networks. ESCAIDE discussions will help shape the future of infectious disease prevention and control, and will ensure we are better equipped to tackle current challenges and prepare for emerging threats.” 

 

ESCAIDE is a hybrid conference with over 3000 participants joining both online and in-person. All participants have access to the online conference platform where they can view live sessions, interact with other participants, and revisit the content after the conference has ended. Online attendance is open and free to anyone. 

Participants include epidemiologists, microbiologists, public health professionals, clinicians, veterinarians, science journalists, statisticians, social scientists and policy makers. 

Learn more